Neostigmine Methylsulfate

Product NDC
70594-072
11-digit product format
705940072
Labeler code
70594
Product ID
70594-072_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Neostigmine Methylsulfate
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Xellia Pharmaceuticals USA LLC
Application
ANDA213074
Marketing category
ANDA
Marketing start
2021-01-10
Substance
NEOSTIGMINE METHYLSULFATE
Active strength
1 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Neostigmine Methylsulfate
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NEOSTIGMINE METHYLSULFATE1 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii98IMH7M386
Rxcui311935, 311936

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f58f10d3-5fa9-4c2e-9a6e-77029e9ed80bProduct name120231002
6c2b16d0-96e9-444e-98c5-9883cd6eb72dProduct name220230316
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
ad279e69-d021-f6bd-1150-2b55f23832d5Product name920211014
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70594-072-01Neostigmine Methylsulfate10 mL in 1 VIALINJECTION103
70594-072-02Neostigmine Methylsulfate10 in 1 CARTONINJECTION103

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70594-072NEOSTIGMINE METHYLSULFATE INJECTION [XELLIA PHARMACEUTICALS USA LLC]3Current NDC, Legacy NDC, 2 package rows20211106_398d8193-e1e8-42b5-a95a-86cde967c7d0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
311935neostigmine methylsulfate 0.5 MG/ML Injectable SolutionPSN398d8193-e1e8-42b5-a95a-86cde967c7d03
311936neostigmine methylsulfate 1 MG/ML Injectable SolutionPSN398d8193-e1e8-42b5-a95a-86cde967c7d03
311935neostigmine methylsulfate 0.5 MG/ML Injectable SolutionSCD398d8193-e1e8-42b5-a95a-86cde967c7d03
311936neostigmine methylsulfate 1 MG/ML Injectable SolutionSCD398d8193-e1e8-42b5-a95a-86cde967c7d03
311935neostigmine methylsulfate 0.5 MG/ML Injectable SolutionSY398d8193-e1e8-42b5-a95a-86cde967c7d03
311936neostigmine methylsulfate 1 MG/ML Injectable SolutionSY398d8193-e1e8-42b5-a95a-86cde967c7d03

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70594-072-017059400720110 mL in 1 VIAL10 mlHistorical
70594-072-027059400720210 VIAL in 1 CARTON (70594-072-02) / 10 mL in 1 VIAL (70594-072-01) 10 vial2021-01-110000-00-00NoNoCurrent